68 Results for "

E7

" in MedChemExpress (MCE) Product Catalog:
Products (68)

68 Results for "E7" in MCE Product Catalog:

72
72 Publications Verification
Cat. No.: HY-B2227B
CAS No.: 72-17-3
Synonyms: DL-Lactic acid sodium; E-270 sodium
Lactic acid (DL-Lactic acid) sodium (60% w/w in water) is a hydroxycarboxylic acid receptor 1 (HCAR1) activator and an epigenetic modulator inducing lysine residues lactylation. Lactic acid sodium (60% w/w in water) is a glycolysis end-product, bridging the gap between glycolysis and oxidative phosphorylation. Lactic acid sodium (60% w/w in water) is an oncometabolite and has immune protective role of lactate in anti-tumor immunity . Lactic acid sodium (60% w/w in water) also has antimicrobial activity, which can be used as a food preservative .
This product has a content (w/w) of 60%, and 1 mL of the system contains 798 mg of Lactic acid sodium, i.e., a concentration of 798 mg/mL (i.e., 7.12 M).
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-120599
CAS No.: 1332881-26-1
Purity:  99.00%
Synonyms: VERU-111; ABI-231
Research Areas:  

Cancer

VERU-111 (ABI-231) is a potent and orally active α and β tubulin inhibitor, which displays strong antiproliferative activity, with an average IC50 of 5.2 nM against panels of melanoma and prostate cancer cell lines. VERU-111 (ABI-231) suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting HPV E6 and E7, and has potential for the treatment of prostate cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-164992
Synonyms: MRG002; Trastuzumab MMAE
Trastuzumab vedotin (MRG002; Trastuzumab MMAE) is an antibody-drug conjugate and cytotoxin targeting HER2, with a Kd of 7.50E-11 M for human HER2. After binding to HER2, Trastuzumab vedotin undergoes internalization and lysosomal trafficking, delivering a cytotoxic payload to HER2-expressing cells and inducing tumor regression in in vivo xenograft models with HER2-expressing tumors. The anti-tumor activity of Trastuzumab vedotin is enhanced when used in combination with anti-PD-1 antibodies, and it exhibits preclinical anti-tumor activity in drug-resistant breast cancer, gastric cancer, and urothelial carcinoma PDX models. Trastuzumab vedotin has low antibody-dependent cellular cytotoxicity activity and can be used in studies related to HER2-positive breast cancer, HER2-positive gastric cancer, and unresectable locally advanced or metastatic HER2-positive urothelial carcinoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124379
CAS No.: 402-71-1
Purity:  98.05%
Synonyms: L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK
TPCK (L-1-Tosylamido-2-phenylethyl chloromethyl ketone; L-TPCK) is an effective serine protease inhibitor and also a blocker of the PDK1/Akt pathway. TPCK can modify the E7 protein in actively keratinocyte cells. TPCK can induce cellular apoptosis, suppress tumor growth, reduce hypoxic-ischemic brain injury in rat pups, and affect vascular permeability in inflamed rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P85128

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P1907
CAS No.: 151812-18-9
Target:  

HPV

Research Areas:  

Cancer

Human Papillomavirus (HPV) E7 protein (49-57) is a cytotoxic T lymphocyte (CTL) epitope peptide derived from HPV16 E7 protein (sequence: RAHYNIVTF). Human Papillomavirus (HPV) E7 protein (49-57) induces E749-57-specific CTL responses. Human Papillomavirus (HPV) E7 protein (49-57) can be used for the research of cervical cancer .
loading...
    loading...
Cat. No.: HY-117389
CAS No.: 172286-77-0
Purity:  99.88%
Synonyms: PK4C9
Target:  

DNA/RNA Synthesis

Research Areas:  

Others

Homocarbonyltopsentin (PK4C9) is a small-molecule TSL2-binding compound, binds to pentaloop conformations of TSL2 and promotes a shift to triloop conformations that display enhanced SMN2 exon 7 (E7) splicing with EC50 value of 16 μM .
loading...
    loading...
Cat. No.: HY-P11303
CAS No.: 161147-59-7
Target:  

CD74 MHC

Research Areas:  

Neurological Disease Cancer

PADRE peptide is a pan-HLA-DR binding epitope and immunostimulant. PADRE peptide binds to the peptide-binding groove of MHC class II molecules for presentation to CD4 + T cells, thereby effectively stimulating specific immune responses. PADRE peptide not only enhances anti-tumor immune responses, inhibits tumor growth and prolongs survival; it also significantly increases the frequency of E7-specific CD8 + T cells and improves therapeutic efficacy against TC-1 tumors when used in combination with E7 peptide-based vaccines and poly (I:C). The intensity of the immune response induced by PADRE peptide is lower than that of the Ii-PADRE DNA vaccine, and it fails to enhance the immune effect of CRT-E7 DNA. PADRE peptide is widely applicable to research on related tumors such as melanoma, glioblastoma and cervical cancer .
loading...
    loading...
Cat. No.: HY-P1778A
Target:  

HPV

Research Areas:  

Infection

HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) TFA is immunogenic in cervical carcinomas .
loading...
    loading...
Cat. No.: HY-P1778
CAS No.: 160212-93-1
Target:  

HPV

Research Areas:  

Infection

HPV16 E7 (86-93) is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) is immunogenic in cervical carcinomas .
loading...
    loading...
Cat. No.: HY-124644
CAS No.: 1565845-92-2
Purity:  95.07%
Target:  

HIV Phosphatase

Research Areas:  

Infection

1E7-03, a low MW tetrahydroquinoline derivative targeting protein phosphatase-1, can inhibit HIV-1 transcription .
loading...
    loading...
Cat. No.: HY-P2299A
Target:  

HPV

Research Areas:  

Cancer

Protein E7(43-62) TFA is an E7-derived peptide with anti-tumor effects (short peptide spanning the 43th to 62th amino acid residues in the E7 protein) .
loading...
    loading...
Cat. No.: HY-134650
CAS No.: 100667-52-5
(4E)-7-(4-Hydroxyphenyl)-1-phenylhept-4-en-3-one (Compound 8) is a diarylheptanoid containing two benzene rings. Diarylheptanoid is widely distributed in Alpinia, and exhibits cytotoxic, anti-inflammatory, antiplatelet, antioxidant, and antiproliferative activities .
loading...
    loading...
Cat. No.: HY-P991453

Research Areas:  

Cancer

Anti-CD371/CLEC12A Antibody (H6e7) is a human monoclonal antibody (mAb) targeting CD371/CLEC12A. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
Cat. No.: HY-P2299
CAS No.: 143853-58-1
Target:  

HPV

Research Areas:  

Cancer

Protein E7(43-62) is an E7-derived peptide with anti-tumor effects (short peptide spanning the 43th to 62th amino acid residues in the E7 protein) .
loading...
    loading...
Cat. No.: HY-146033
CAS No.: 331851-78-6
Target:  

HPV

Research Areas:  

Cancer

HPV18-IN-1 (Compound H1) is a potent inhibitor of HPV18. HPV18-IN-1 prevents cervical cancer cells from premature cell procession and abnormal proliferation. HPV18-IN-1 supresses E7-Rb-E2F cellular pathway and DNA methylation. HPV18-IN-1 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-P1881
CAS No.: 160040-04-0
Target:  

HPV

Research Areas:  

Cancer

HPV16-E711-20 epitope is a well-known HLA-A *0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. HPV16 CTL epitopes may be good candidates for the development of an effective peptide-based antitumor vaccine .
loading...
    loading...
Cat. No.: HY-P72259
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Protein E7; E7
Species:  
Virus
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P702859
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Protein E7; E7
Species:  
Virus
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-135883
CAS No.: 2283420-62-0
Target:  

Pyruvate Kinase

Research Areas:  

Cardiovascular Disease

PKR activator 1 is a potent pyruvate kinase-R (PKR) activator extracted from patent WO2019035865A1, compound E7-93 .
loading...
    loading...